Ceftazidime dosage regimen recommendations in burn patients based on a Monolix population pharmacokinetic study.

The aim of our present work was to predict in burn patients the best adapted ceftazidime dosage regimen to obtain a serum target of 40 to 100 mg/l taking into account the influence of patients' characteristics on ceftazidime pharmacokinetics (PK).